-
1
-
-
0026848689
-
Relevancia de la mortalidad por enfermedades del aparato cardiocirculatorio en España
-
Banegas JR, Villar F, Martín JM, Rodríguez-Artalejo F, González J. Relevancia de la mortalidad por enfermedades del aparato cardiocirculatorio en España. Rev Clin Esp 1992; 190: 321-7.
-
(1992)
Rev Clin Esp
, vol.190
, pp. 321-327
-
-
Banegas, J.R.1
Villar, F.2
Martín, J.M.3
Rodríguez-Artalejo, F.4
González, J.5
-
2
-
-
0017885465
-
Coronary heart disease in relation to age, sex and the menopause
-
Heller RF. Coronary heart disease in relation to age, sex and the menopause. Br Med J 1987; 1: 472-4.
-
(1987)
Br Med J
, vol.1
, pp. 472-474
-
-
Heller, R.F.1
-
3
-
-
0025981467
-
Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
-
Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
-
(1991)
Prev Med
, vol.20
, pp. 47-63
-
-
Stampfer, M.J.1
Colditz, G.A.2
-
4
-
-
0033600608
-
Beta-estradiol delivered by three different matrix patches 50 microg/day
-
Rohr UD, Nauert C, Stehle B. Beta-estradiol delivered by three different matrix patches 50 microg/day. Maturitas 1999; 33: 45-58.
-
(1999)
Maturitas
, vol.33
, pp. 45-58
-
-
Rohr, U.D.1
Nauert, C.2
Stehle, B.3
-
5
-
-
0345346372
-
Absorption and bioavilability of oestradiol from a gel, a patch and a tablet
-
Jarvinen A, Nykanen S, Paasiniemi L. Absorption and bioavilability of oestradiol from a gel, a patch and a tablet. Maturitas 1999; 32: 103-13.
-
(1999)
Maturitas
, vol.32
, pp. 103-113
-
-
Jarvinen, A.1
Nykanen, S.2
Paasiniemi, L.3
-
6
-
-
0022995571
-
Effects of natural oestrogen/progestogen substitution therapy on carbohidrate metabolism postmenopausal women
-
Luotola H, Pyorälä T, Loikkannen M. Effects of natural oestrogen/progestogen substitution therapy on carbohidrate metabolism postmenopausal women. Maturitas 1986; 8: 243-53.
-
(1986)
Maturitas
, vol.8
, pp. 243-253
-
-
Luotola, H.1
Pyorälä, T.2
Loikkannen, M.3
-
7
-
-
8544267912
-
Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM
-
Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, Krans HM. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 1997; 407: 843-9.
-
(1997)
Diabetologia
, vol.407
, pp. 843-849
-
-
Brussaard, H.E.1
Gevers Leuven, J.A.2
Frolich, M.3
Kluft, C.4
Krans, H.M.5
-
8
-
-
0032768676
-
Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women
-
Chmouliovsky L, Habicht F, James RW, Lehmann T, Campana A, Golay A. Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women. Maturitas 1999; 32: 147-53.
-
(1999)
Maturitas
, vol.32
, pp. 147-153
-
-
Chmouliovsky, L.1
Habicht, F.2
James, R.W.3
Lehmann, T.4
Campana, A.5
Golay, A.6
-
9
-
-
0033059385
-
Increased serum levels of growth hormone and insulin-like grow factor-I associated with simultaneous decrease of circulating insulin of post-menopausal women reiciving hormone replacement therapy
-
Fonseca E, Ochoa R, Galvan R, Hernández M, Mercado M, Zarate A. Increased serum levels of growth hormone and insulin-like grow factor-I associated with simultaneous decrease of circulating insulin of post-menopausal women reiciving hormone replacement therapy. Menopause 1999; 6: 56-60.
-
(1999)
Menopause
, vol.6
, pp. 56-60
-
-
Fonseca, E.1
Ochoa, R.2
Galvan, R.3
Hernández, M.4
Mercado, M.5
Zarate, A.6
-
10
-
-
0027757125
-
Oral versus transdermal hormonal replacement therapy
-
Stevenson JC, Crook D, Godsland IF, Lees B, Whitehead MI. Oral versus transdermal hormonal replacement therapy. Int J Fertil Menop S 1993; 38: 30-5.
-
(1993)
Int J Fertil Menop S
, vol.38
, pp. 30-35
-
-
Stevenson, J.C.1
Crook, D.2
Godsland, I.F.3
Lees, B.4
Whitehead, M.I.5
-
11
-
-
0031573868
-
The effect of transdermal 17b-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration
-
Cagnacci A, Tuveri F, Cirilo R, Setteneri AH, Melis GB, Volpe A. The effect of transdermal 17b-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration. Maturitas 1997; 28: 163-7.
-
(1997)
Maturitas
, vol.28
, pp. 163-167
-
-
Cagnacci, A.1
Tuveri, F.2
Cirilo, R.3
Setteneri, A.H.4
Melis, G.B.5
Volpe, A.6
-
12
-
-
0031682105
-
Effect of postmenopausal hormone therapy on glucose and insulin concentrations
-
PEPI investigators
-
Espeland MA, Hogan PE, Fineberg SE, Howard G, Schrott H, Waclawiw MA, et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI investigators. Diabetes Care 1998; 21: 1589-95.
-
(1998)
Diabetes Care
, vol.21
, pp. 1589-1595
-
-
Espeland, M.A.1
Hogan, P.E.2
Fineberg, S.E.3
Howard, G.4
Schrott, H.5
Waclawiw, M.A.6
-
13
-
-
0033788248
-
Hormone replacement therapy and glucose metabolism
-
Triusu RJ, Cowie CC, Harris MI. Hormone replacement therapy and glucose metabolism. Obstet Gynecol 2000; 96: 665-70.
-
(2000)
Obstet Gynecol
, vol.96
, pp. 665-670
-
-
Triusu, R.J.1
Cowie, C.C.2
Harris, M.I.3
-
14
-
-
0026035002
-
Plasma Lp(a) concentration after oestrogen and progestogen in postmenopausal women
-
Soma M, Fumagalli R, Paoletti R, Meschia M, Carena Maini M, Crosignani P, et al. Plasma Lp(a) concentration after oestrogen and progestogen in postmenopausal women. Lancet 1991; 337: 612.
-
(1991)
Lancet
, vol.337
, pp. 612
-
-
Soma, M.1
Fumagalli, R.2
Paoletti, R.3
Meschia, M.4
Carena Maini, M.5
Crosignani, P.6
-
15
-
-
0027401344
-
Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women
-
Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, et al. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328: 1069-75.
-
(1993)
N Engl J Med
, vol.328
, pp. 1069-1075
-
-
Nabulsi, A.A.1
Folsom, A.R.2
White, A.3
Patsch, W.4
Heiss, G.5
Wu, K.K.6
-
16
-
-
0026439756
-
Beneficial effect on serum lipoproteins by 17-oestradiol-dydrogesterone therapy in postmenopausal women: A prospective study
-
Van der Mooren MJ, Demacker PNM, Thomas CMG, Rolland R. Beneficial effect on serum lipoproteins by 17-oestradiol-dydrogesterone therapy in postmenopausal women: a prospective study. Eur J Obstet Gynecol Reprod Biol 1992; 47: 143-60.
-
(1992)
Eur J Obstet Gynecol Reprod Biol
, vol.47
, pp. 143-160
-
-
Van der Mooren, M.J.1
Demacker, P.N.M.2
Thomas, C.M.G.3
Rolland, R.4
-
17
-
-
0028091144
-
Effect of continuous combined estrogen replacement therapy on serum lipids and lipoproteins
-
Marsh MS, Crook D, Ellerington MC, Whittecroft SI, Whitehead MI, Stevenson JC. Effect of continuous combined estrogen replacement therapy on serum lipids and lipoproteins. Obstet Gynecol 1994; 83: 19-23.
-
(1994)
Obstet Gynecol
, vol.83
, pp. 19-23
-
-
Marsh, M.S.1
Crook, D.2
Ellerington, M.C.3
Whittecroft, S.I.4
Whitehead, M.I.5
Stevenson, J.C.6
-
18
-
-
0032539907
-
Effect of postmenopausal hormone therapy on lipoprotein (a) concentration
-
PEPI Investigators
-
Espeland MA, Marcovina SM, Miller V, Wood PD, Wasilauskas C, Shervin R, et al. Effect of postmenopausal hormone therapy on lipoprotein (a) concentration. PEPI Investigators. Circulation 1998; 97: 979-86.
-
(1998)
Circulation
, vol.97
, pp. 979-986
-
-
Espeland, M.A.1
Marcovina, S.M.2
Miller, V.3
Wood, P.D.4
Wasilauskas, C.5
Shervin, R.6
-
19
-
-
0032547326
-
Randomized trial of estrogen plus progestin for secundary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS)
-
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secundary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS). JAMA 1998; 280: 605-13.
-
(1998)
JAMA
, vol.280
, pp. 605-613
-
-
Hulley, S.1
Grady, D.2
Bush, T.3
Furberg, C.4
Herrington, D.5
Riggs, B.6
-
20
-
-
0025826017
-
Lipoprotein (a) concentrations in postmenopausal women taking norethisterona
-
Farish E, Rolton HA, Barnes JF. Lipoprotein (a) concentrations in postmenopausal women taking norethisterona. Br Med J 1991; 303: 694.
-
(1991)
Br Med J
, vol.303
, pp. 694
-
-
Farish, E.1
Rolton, H.A.2
Barnes, J.F.3
-
21
-
-
0034529594
-
The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in postmenopausal women
-
Seed M, Sands RH, McLaren M, Kirk G, Darko D. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in postmenopausal women. Fam Pract 2000; 17: 497-507.
-
(2000)
Fam Pract
, vol.17
, pp. 497-507
-
-
Seed, M.1
Sands, R.H.2
McLaren, M.3
Kirk, G.4
Darko, D.5
-
22
-
-
0034020783
-
Lipoproteins and lowdose estradiol replacement therapy in postmenopausal type 2 diabetic patients: The effect of addition of norethisterone acetate
-
Owens D, Collins PB, Johnson A, Tomkin GH. Lipoproteins and lowdose estradiol replacement therapy in postmenopausal type 2 diabetic patients: the effect of addition of norethisterone acetate. Diabet Med 2000; 17: 308-15.
-
(2000)
Diabet Med
, vol.17
, pp. 308-315
-
-
Owens, D.1
Collins, P.B.2
Johnson, A.3
Tomkin, G.H.4
-
23
-
-
0033365205
-
Plasma lipids, lipoprotein (a), apolipoproteins and hemostatic risk factors distributions in postmenopausal women
-
Cubrillo-Turek M, Stavljenic-Rukavina A, Reiner Z, Zrinski R. Plasma lipids, lipoprotein (a), apolipoproteins and hemostatic risk factors distributions in postmenopausal women. Acta Med Croatica 1999; 53: 61-6.
-
(1999)
Acta Med Croatica
, vol.53
, pp. 61-66
-
-
Cubrillo-Turek, M.1
Stavljenic-Rukavina, A.2
Reiner, Z.3
Zrinski, R.4
-
24
-
-
77957126077
-
The menopausal Estrogen/Progestin Intervention trial (PEPI). Effects of estrogen/progesteron regimens on heart disease risk factors in postmenopausal women
-
The menopausal Estrogen/Progestin Intervention trial (PEPI). Effects of estrogen/progesteron regimens on heart disease risk factors in postmenopausal women. JAMA 1995; 273: 199-208.
-
(1995)
JAMA
, vol.273
, pp. 199-208
-
-
-
25
-
-
0033998862
-
The effects of THS on hemostatic variables in women with angiographically coronary artery disease: Results from the estrogen in women with artherosclerosis study
-
Hoibraaten E, Os I, Seljeflot I, Andersen TO, Hofstad A, Sandset PM. The effects of THS on hemostatic variables in women with angiographically coronary artery disease: results from the estrogen in women with artherosclerosis study. Thromb Res 2000; 98: 19-27.
-
(2000)
Thromb Res
, vol.98
, pp. 19-27
-
-
Hoibraaten, E.1
Os, I.2
Seljeflot, I.3
Andersen, T.O.4
Hofstad, A.5
Sandset, P.M.6
-
26
-
-
0033175413
-
The influence the hormone replacement therapy containing transdermal 17b-estradiol and medroxyprogesterone acetate on coagulation and fibrinolysis
-
Stachowcak G, Owizarak D, Polec I, Pertynski T, Jedrzejczyk S. The influence the hormone replacement therapy containing transdermal 17b-estradiol and medroxyprogesterone acetate on coagulation and fibrinolysis. Ginecol Pol 1999; 70: 527-33.
-
(1999)
Ginecol Pol
, vol.70
, pp. 527-533
-
-
Stachowcak, G.1
Owizarak, D.2
Polec, I.3
Pertynski, T.4
Jedrzejczyk, S.5
-
27
-
-
0030048374
-
Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women
-
Meilahan EN, Cauley JA, Tracy RP, Macy ED, Gutai JP, Kuller LH. Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women. Am J Epidemiol 1996; 143: 159-66.
-
(1996)
Am J Epidemiol
, vol.143
, pp. 159-166
-
-
Meilahan, E.N.1
Cauley, J.A.2
Tracy, R.P.3
Macy, E.D.4
Gutai, J.P.5
Kuller, L.H.6
-
28
-
-
0030784934
-
The effects of transdermal oestradiol and oral progestogens on haemostasis variables
-
Kroon UB, Tengborn L, Rita H, Backstrom AC. The effects of transdermal oestradiol and oral progestogens on haemostasis variables. Br J Obstet Gynecol 1997; 104 Supl. 16: 32-7.
-
(1997)
Br J Obstet Gynecol
, vol.104
, Issue.SUPPL. 16
, pp. 32-37
-
-
Kroon, U.B.1
Tengborn, L.2
Rita, H.3
Backstrom, A.C.4
-
29
-
-
0034661530
-
Total homocysteine and estrogen indicators in the Third National and Nutrition Examination Survey
-
Morris MS, Jacques PF, Selhub J, Rosenberg IH. Total homocysteine and estrogen indicators in the Third National and Nutrition Examination Survey. Am J Epidemiol 2000; 152: 140-8.
-
(2000)
Am J Epidemiol
, vol.152
, pp. 140-148
-
-
Morris, M.S.1
Jacques, P.F.2
Selhub, J.3
Rosenberg, I.H.4
-
30
-
-
0032030666
-
A randomised controlled study of the effects of 17b-oestradiol-dydrogesterone on plasma homocysteine in postmenopausal women
-
Mijatovic V, Kenemans P, Jacobs C, Van Baal WM, Peters-Muller ERA, Van der Mooren MJ. A randomised controlled study of the effects of 17b-oestradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 1998; 91: 432-6.
-
(1998)
Obstet Gynecol
, vol.91
, pp. 432-436
-
-
Mijatovic, V.1
Kenemans, P.2
Jacobs, C.3
Van Baal, W.M.4
Peters-Muller, E.R.A.5
Van der Mooren, M.J.6
-
31
-
-
0032403666
-
Randomiced, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine in healthy postmenopausal women
-
Mijatovic N, Netelenbos JC, Van de Mooren MJ, de Valke-de Roo G, Jakobs C, Kenemans P. Randomiced, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine in healthy postmenopausal women. Fertil Steril 1998; 70: 1085-9.
-
(1998)
Fertil Steril
, vol.70
, pp. 1085-1089
-
-
Mijatovic, N.1
Netelenbos, J.C.2
Van de Mooren, M.J.3
De Valke-de Roo, G.4
Jakobs, C.5
Kenemans, P.6
-
32
-
-
0032870857
-
Hormone replacement therapy and plasma homocysteine levels
-
Van Baal WM, Smolders RG, Van der Mooren MJ, Teerlink T, Kenemans P. Hormone replacement therapy and plasma homocysteine levels. Obstet Gynecol 1999; 94: 485-91.
-
(1999)
Obstet Gynecol
, vol.94
, pp. 485-491
-
-
Van Baal, W.M.1
Smolders, R.G.2
Van der Mooren, M.J.3
Teerlink, T.4
Kenemans, P.5
-
33
-
-
0032552636
-
Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease
-
Van der Mooren MJ, Mijatovich V, Van Vaal WM, Stehouver CDA. Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease. Maturitas 1998; 30: 27-36.
-
(1998)
Maturitas
, vol.30
, pp. 27-36
-
-
Van der Mooren, M.J.1
Mijatovich, V.2
Van Vaal, W.M.3
Stehouver, C.D.A.4
-
34
-
-
0028143396
-
Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women
-
Van der Mooren MJ, Wouters MG, Blom HJ, Schellekens LA, Eskes TK, Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest 1994; 24: 733-6.
-
(1994)
Eur J Clin Invest
, vol.24
, pp. 733-736
-
-
Van der Mooren, M.J.1
Wouters, M.G.2
Blom, H.J.3
Schellekens, L.A.4
Eskes, T.K.5
Rolland, R.6
-
35
-
-
0032741765
-
Plasma homocysteine in women taking hormone replacement therapy: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
-
Barnabei VM, Phillips TM, Hsia J. Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Womens Health Gend Based Med 1999; 8: 1167-72.
-
(1999)
J Womens Health Gend Based Med
, vol.8
, pp. 1167-1172
-
-
Barnabei, V.M.1
Phillips, T.M.2
Hsia, J.3
-
36
-
-
0033638421
-
Failure of the combination of sequential oral and transdermal estradiol plusnorethisterone acetate to affect plasma homocysteine levels
-
Evio S, Tiitinen A, Turpeinen U, Ylikorkala O. Failure of the combination of sequential oral and transdermal estradiol plusnorethisterone acetate to affect plasma homocysteine levels. Fertil Steril 2000; 74: 1080-3.
-
(2000)
Fertil Steril
, vol.74
, pp. 1080-1083
-
-
Evio, S.1
Tiitinen, A.2
Turpeinen, U.3
Ylikorkala, O.4
-
37
-
-
0033981051
-
The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women
-
Berger PB, Herrmann RR, Dumesic DA. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women. Mayo Clin Proc 2000; 75: 18-23.
-
(2000)
Mayo Clin Proc
, vol.75
, pp. 18-23
-
-
Berger, P.B.1
Herrmann, R.R.2
Dumesic, D.A.3
-
38
-
-
0032893058
-
Hormone replacement therapy, inflammation and hemostasis in elderly women
-
Cushman M, Meilhan EN, Psaty BM, et al. Hormone replacement therapy, inflammation and hemostasis in elderly women. Arterioscler Thromb Vasc Biol 1999; 19: 893-9.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 893-899
-
-
Cushman, M.1
Meilhan, E.N.2
Psaty, B.M.3
-
39
-
-
0033578485
-
Hormone replacement therapy and increased plasma concentration of C-Reactive Protein
-
Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. Hormone replacement therapy and increased plasma concentration of C-Reactive Protein. Circulation 1999; 100: 713-6.
-
(1999)
Circulation
, vol.100
, pp. 713-716
-
-
Ridker, P.M.1
Hennekens, C.H.2
Rifai, N.3
Buring, J.E.4
Manson, J.E.5
-
40
-
-
0033578463
-
Effect of postmenopausal hormones on inflammation-sensitive proteins. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
-
Cushman M, Legault C, Barret-Connor E, Stefanick M, Kessler C, Judd H, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 1999; 100: 717-22.
-
(1999)
Circulation
, vol.100
, pp. 717-722
-
-
Cushman, M.1
Legault, C.2
Barret-Connor, E.3
Stefanick, M.4
Kessler, C.5
Judd, H.6
-
41
-
-
0033035841
-
Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women
-
Van Baal WM, Kenemans P, Van der Mooren MJ, et al. Increased C-Reactive Protein levels during short-term hormone replacement therapy in healthy postmenopausal women. Thromb Haemost 1998; 81: 925-8.
-
(1998)
Thromb Haemost
, vol.81
, pp. 925-928
-
-
Van Baal, W.M.1
Kenemans, P.2
Van der Mooren, M.J.3
-
42
-
-
0035067690
-
Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinilysis, inflammation and serum lipids and lipoproteins in postmenopausal women
-
Vehkavaara S, Silveira A, Hakala-Ala-Pietila T, et al. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinilysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost 2001; 85: 619-25.
-
(2001)
Thromb Haemost
, vol.85
, pp. 619-625
-
-
Vehkavaara, S.1
Silveira, A.2
Hakala-Ala-Pietila, T.3
-
43
-
-
0034907754
-
Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein. A cross-sectional population survey
-
Lowe GD, Upton MN, Rumley A, et al. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein. A cross-sectional population survey. Thomb Haemost 2001; 86: 550-6
-
(2001)
Thomb Haemost
, vol.86
, pp. 550-556
-
-
Lowe, G.D.1
Upton, M.N.2
Rumley, A.3
-
44
-
-
0037007133
-
Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women
-
Koh KK, Schenke WH, Waclawiw MA, Csako G, Cannon RO 3rd. Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women. Circulation 2002; 105: 1531-3.
-
(2002)
Circulation
, vol.105
, pp. 1531-1533
-
-
Koh, K.K.1
Schenke, W.H.2
Waclawiw, M.A.3
Csako, G.4
Cannon R.O. III5
|